Stockscreener 앱 받기
1.36
4.23%
-0.06
전일 마감가:
$1.42
열려 있는:
$1.4
하루 거래량:
140.85K
Relative Volume:
0.33
시가총액:
$82.38M
수익:
-
순이익/손실:
$-64.86M
주가수익비율:
-1.2143
EPS:
-1.12
순현금흐름:
$-55.66M
1주 성능:
+0.74%
1개월 성능:
+12.40%
6개월 성능:
-2.86%
1년 성능:
-50.36%
1일 변동 폭
$1.36
$1.42
1주일 범위
$1.29
$1.47
52주 변동 폭
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
명칭
Acumen Pharmaceuticals Inc
전화
925-368-8508
주소
427 PARK ST., CHARLOTTESVILLE
ABOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
1.36 | 84.80M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-07-26 | 개시 | Citigroup | Buy |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-07-20 | 재개 | BofA Securities | Buy |
| 2023-05-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-07-15 | 개시 | BTIG Research | Buy |
| 2022-06-30 | 개시 | H.C. Wainwright | Buy |
| 2022-01-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-07-26 | 개시 | BofA Securities | Neutral |
| 2021-07-26 | 개시 | Credit Suisse | Outperform |
| 2021-07-26 | 개시 | Stifel | Buy |
| 2021-07-26 | 개시 | UBS | Buy |
모두보기
Acumen Pharmaceuticals Inc 주식(ABOS)의 최신 뉴스
Using economic indicators to assess Acumen Pharmaceuticals Inc. potentialImmediate Entry Point Prediction Strategy - Newser
Acumen Pharmaceuticals Inc. stock momentum explainedTrade Safety Matrix for Conservative Traders - Newser
Will Acumen Pharmaceuticals Inc. benefit from macro trendsFast Return Equity Forecast With Logic - Newser
Using data tools to time your Acumen Pharmaceuticals Inc. exitHigh Return Strategy with Low Risk - Newser
What’s next for Acumen Pharmaceuticals Inc. stock priceWatchlist Generator With Real-Time Entry - Newser
What makes Acumen Pharmaceuticals Inc. stock price move sharplyChart Driven Opportunity Scanner with Alerts - Newser
Acumen Pharmaceuticals Inc. Building a Base Near SupportAI Powered High Return Stock Calls Dominate Watchlists - beatles.ru
Can machine learning forecast Acumen Pharmaceuticals Inc. recoverySwing Trade Watchlist with Entry Zones - Newser
Is Acumen Pharmaceuticals Inc. stock entering bullish territory3-Day Market Movement Forecast Analysis - Newser
Acumen Pharmaceuticals (ABOS) Projected to Post Quarterly Earnings on Tuesday - Defense World
Advanced analytics toolkit walkthrough for Acumen Pharmaceuticals Inc.Expert-Backed High Yield Stock Watchlist - Newser
How to build a dashboard for Acumen Pharmaceuticals Inc. stockEntry Optimization Tool with Screener Logic - Newser
Analyzing drawdowns of Acumen Pharmaceuticals Inc. with statistical toolsFree Technical Stock Breakout Predictions - Newser
Key metrics from Acumen Pharmaceuticals Inc.’s quarterly dataFree Wealth Building Stock Market Ideas - Newser
Evaluating Acumen Pharmaceuticals Inc. with trendline analysisFree Triple Digit Growth Focused Trade Plan - Newser
Earnings visualization tools for Acumen Pharmaceuticals Inc.Free AI Screening for Swing Trade Picks - Newser
How Acumen Pharmaceuticals Inc. stock performs during market volatilityDaily Market Movers Screener with Filters - Newser
How to monitor Acumen Pharmaceuticals Inc. with trend dashboardsShort Term Opportunity Finder with Tools - Newser
Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times
Acumen Pharmaceuticals Sets Q2 Earnings Date: Key Updates Expected on Alzheimer's Drug Development - Stock Titan
Exit strategy if you’re trapped in Acumen Pharmaceuticals Inc.Short-Term Support and Resistance Forecast - Newser
Top Risks to Consider Before Buying Acumen Pharmaceuticals Inc. StockDaily Stock Forecast Powered by AI Tools - Newser
How volatile is Acumen Pharmaceuticals Inc. stock compared to the marketAchieve rapid portfolio appreciation today - Jammu Links News
What drives Acumen Pharmaceuticals Inc. stock priceConsistently outstanding ROI - Jammu Links News
How many analysts rate Acumen Pharmaceuticals Inc. as a “Buy”Achieve breakthrough profits with expert advice - Jammu Links News
How strong is Acumen Pharmaceuticals Inc. company’s balance sheetAccess powerful market insights for free - Jammu Links News
What institutional investors are buying Acumen Pharmaceuticals Inc. stockInvest with confidence backed by data - Jammu Links News
What are Acumen Pharmaceuticals Inc. company’s key revenue driversMassive profits - Jammu Links News
Why is Acumen Pharmaceuticals Inc. stock attracting strong analyst attentionRecord-breaking capital gains - Jammu Links News
Is Acumen Pharmaceuticals Inc. a growth stock or a value stockMaximize portfolio value with timely trades - Jammu Links News
What catalysts could drive Acumen Pharmaceuticals Inc. stock higher in 2025Maximize returns with strategic stock selection - Jammu Links News
Acumen Pharmaceuticals’ Promising Alzheimer’s Study: A Potential Game-Changer? - TipRanks
When is Acumen Pharmaceuticals Inc. stock expected to show significant growthWealth Building Picks That Work - Jammu Links News
Acumen Pharmaceuticals Inc (ABOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acumen Pharmaceuticals Inc 주식 (ABOS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zuga Matt | CFO & Chief Business Officer |
Jan 21 '25 |
Sale |
1.60 |
4,364 |
6,986 |
260,646 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '25 |
Sale |
1.59 |
12,619 |
20,102 |
667,488 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '25 |
Sale |
1.59 |
3,418 |
5,435 |
161,127 |
| Barton Russell | Chief Operating Officer |
Jan 21 '25 |
Sale |
1.61 |
2,914 |
4,692 |
136,117 |
| Siemers Eric | Chief Medical Officer |
Jan 21 '25 |
Sale |
1.59 |
3,219 |
5,118 |
170,298 |
0.24%
3.39%
자본화:
|
볼륨(24시간):